X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1592) 1592
Publication (124) 124
Newsletter (32) 32
Book Chapter (24) 24
Book Review (19) 19
Magazine Article (8) 8
Newspaper Article (7) 7
Conference Proceeding (6) 6
Trade Publication Article (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1015) 1015
cinacalcet (1014) 1014
index medicus (704) 704
cinacalcet hydrochloride (673) 673
secondary hyperparathyroidism (626) 626
male (555) 555
female (541) 541
naphthalenes - therapeutic use (508) 508
urology & nephrology (501) 501
middle aged (469) 469
hyperparathyroidism (432) 432
hyperparathyroidism, secondary - drug therapy (410) 410
parathyroid hormone (399) 399
parathyroid hormone - blood (343) 343
adult (307) 307
aged (303) 303
calcium (279) 279
hemodialysis (272) 272
calcium - blood (263) 263
hyperparathyroidism, secondary - etiology (253) 253
renal dialysis (250) 250
kidney failure, chronic - complications (240) 240
parathyroidectomy (235) 235
treatment outcome (226) 226
hemodialysis-patients (214) 214
calcium-sensing receptor (193) 193
vitamin d (190) 190
chronic kidney-disease (185) 185
dialysis (179) 179
kidney failure, chronic - therapy (175) 175
calcimimetic agents - therapeutic use (169) 169
calcimimetics (167) 167
hyperparathyroidism, secondary - blood (157) 157
hypercalcemia (155) 155
transplantation (155) 155
parathyroid-hormone (154) 154
dialysis patients (136) 136
naphthalenes - pharmacology (136) 136
care and treatment (135) 135
mortality (131) 131
animals (129) 129
chronic kidney disease (129) 129
endocrinology & metabolism (129) 129
nephrology (128) 128
phosphorus - blood (125) 125
surgery (125) 125
mineral metabolism (124) 124
stage renal-disease (124) 124
disease (117) 117
medicine & public health (117) 117
pharmacology & pharmacy (116) 116
kidney diseases (114) 114
chronic kidney failure (111) 111
naphthalenes - adverse effects (111) 111
hyperparathyroidism - drug therapy (109) 109
cinacalcet hcl (108) 108
naphthalenes - administration & dosage (107) 107
prospective studies (105) 105
vitamin d - therapeutic use (105) 105
kidney transplantation (103) 103
calcimimetic (99) 99
renal dialysis - adverse effects (99) 99
cardiovascular-disease (98) 98
risk factors (98) 98
vascular calcification (98) 98
time factors (97) 97
cinacalcet hydrochloride - therapeutic use (96) 96
phosphorus (96) 96
calcium - metabolism (94) 94
retrospective studies (94) 94
therapy (94) 94
vitamin-d (94) 94
research (93) 93
hcl (90) 90
hypercalcemia - drug therapy (86) 86
calcification (85) 85
drug therapy (83) 83
medicine, general & internal (83) 83
health aspects (82) 82
primary hyperparathyroidism (82) 82
analysis (81) 81
rats (78) 78
metabolism (75) 75
hypercalcemia - etiology (74) 74
patients (72) 72
management (70) 70
receptors, calcium-sensing - metabolism (70) 70
biomarkers - blood (69) 69
persistent hyperparathyroidism (69) 69
aged, 80 and over (68) 68
kidneys (68) 68
receptors, calcium-sensing - agonists (67) 67
renal insufficiency, chronic - complications (67) 67
drug therapy, combination (65) 65
internal medicine (64) 64
chronic-renal-failure (63) 63
follow-up studies (63) 63
abridged index medicus (61) 61
calcitriol (61) 61
hyperparathyroidism, secondary - surgery (61) 61
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1413) 1413
Spanish (71) 71
French (47) 47
Japanese (44) 44
German (35) 35
Polish (18) 18
Italian (13) 13
Czech (5) 5
Danish (4) 4
Portuguese (3) 3
Chinese (1) 1
Korean (1) 1
Russian (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Kidney Diseases, ISSN 0272-6386, 04/2018, Volume 71, Issue 4, pp. 502 - 515
Journal Article
JAMA, ISSN 0098-7484, 01/2017, Volume 317, Issue 2, pp. 156 - 164
IMPORTANCE: Secondary hyperparathyroidism contributes to extraskeletal calcification and is associated with all-cause and cardiovascular mortality. Control is... 
MEDICINE, GENERAL & INTERNAL | CALCIUM-SENSING RECEPTOR | PEPTIDE AGONIST | EVOLVE TRIAL | CARDIOVASCULAR-DISEASE | MINERAL METABOLISM | BONE | CHRONIC KIDNEY-DISEASE | AMG 416 VELCALCETIDE | FGF23 | DIALYSIS | Calcimimetic Agents - administration & dosage | Nausea - chemically induced | Cinacalcet Hydrochloride - pharmacology | Humans | Middle Aged | Calcium - administration & dosage | Male | Cinacalcet Hydrochloride - administration & dosage | Parathyroid Hormone - blood | Peptides - administration & dosage | Calcium - blood | Time Factors | Calcimimetic Agents - pharmacology | Cinacalcet Hydrochloride - adverse effects | Female | Double-Blind Method | Hyperparathyroidism, Secondary - drug therapy | Administration, Oral | Biomarkers - blood | Calcimimetic Agents - adverse effects | Peptides - pharmacology | Kidney Failure, Chronic - therapy | Hyperparathyroidism, Secondary - blood | Vomiting - chemically induced | Fibroblast Growth Factors - blood | Kidney Failure, Chronic - complications | Infusions, Intravenous | Hyperparathyroidism, Secondary - etiology | Peptides - adverse effects | Renal Dialysis | Complications and side effects | Usage | Care and treatment | Parathyroid hormone | Hemodialysis | Dosage and administration | Research | Cinacalcet | Hyperparathyroidism | Patient safety | Endocrine system | Hyperthyroidism | Clinical outcomes
Journal Article
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, ISSN 1720-8386, 02/2019, Volume 42, Issue 2, pp. 243 - 244
Journal Article
Kidney International, ISSN 0085-2538, 05/2019, Volume 95, Issue 5, pp. 1012 - 1014
Calcimimetics are widely used in patients on dialysis to treat secondary hyperparathyroidism. Our current view is that bone effects are only indirect through... 
DIALYSIS PATIENTS | CINACALCET | UROLOGY & NEPHROLOGY
Journal Article
Medicina Clinica, ISSN 0025-7753, 03/2018, Volume 150, Issue 6, pp. 226 - 232
Primary hyperparathyroidism (PHPT) is a common endocrinological process, characterized by chronic elevation of serum concentrations of calcium and parathyroid... 
Cinacalcet | Parathyroid hormone | Primary hyperparathyroidism
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 07/2015, Volume 24, Issue 7, pp. 738 - 747
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 26, pp. 2482 - 2494
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 03/2016, Volume 11, Issue 3, pp. 539 - 546
Journal Article
Biomedical Chromatography, ISSN 0269-3879, 10/2019, Volume 33, Issue 10, pp. e4631 - n/a
A liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the determination of cinacalcet in human plasma was developed and validated. This assay... 
pharmacokinetics | cinacalcet | cinacalcet‐d4 | food effect | LC–MS/MS | CHEMISTRY, ANALYTICAL | LC-MS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BIOCHEMICAL RESEARCH METHODS | PHARMACOLOGY & PHARMACY | cinacalcet-d4 | HYDROCHLORIDE | Cinacalcet | Mass spectrometry | Formic acid | Methods | Organic acids | Index Medicus
Journal Article
British Medical Bulletin, ISSN 0007-1420, 03/2019, Volume 129, Issue 1, pp. 53 - 67
Abstract Introduction The presentation of primary hyperparathyroidism (PHPT) has shifted from a disease characterized by renal and skeletal complications to a... 
cinacalcet | primary hyperparathyroidism | conservative management | parathyroidectomy | hypercalcaemia
Journal Article